Sectra gets FDA nod for digital pathology module

By LabPulse.com staff writers

April 1, 2020 -- Digital image management developer Sectra has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology module.

The digital pathology module is already in use in the U.S. for research purposes and by tumor boards. FDA approval expands its utility to primary diagnostics, which are especially important in complex cancer cases, the company noted.

The module can be used with Leica Biosystems' AT2 DX scanner.

Sectra secures digital pathology contract in Switzerland
Digital image management developer Sectra said it signed a contract with Geneva University Hospital for the company's digital pathology software.
Sectra expands Dutch contract to digital pathology
Digital image management developer Sectra has signed a contract to expand its software installation at a Dutch hospital to include digital pathology.
Leica, Sectra plan joint FDA filing in digital pathology
Pathology workflow solutions company Leica Biosystems and medical imaging specialist Sectra plan to jointly file for 510(k) clearance from the U.S. Food...
Smaller labs eye digital pathology options to improve workflow
As workloads increase in laboratory medicine, some pathology labs have considered harnessing new technologies to improve workflow and efficiency. One...

Copyright © 2020 LabPulse.com

Last Updated np 4/1/2020 11:21:16 AM